{"id":47640,"date":"2012-06-19T04:13:30","date_gmt":"2012-06-19T04:13:30","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/anti-cocaine-vaccine-described-in-human-gene-therapy-journal.php"},"modified":"2012-06-19T04:13:30","modified_gmt":"2012-06-19T04:13:30","slug":"anti-cocaine-vaccine-described-in-human-gene-therapy-journal","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/gene-therapy\/anti-cocaine-vaccine-described-in-human-gene-therapy-journal.php","title":{"rendered":"Anti-cocaine vaccine described in Human Gene Therapy Journal"},"content":{"rendered":"<p><p>Public  release date: 18-Jun-2012  [ |   E-mail   |  Share    ]  <\/p>\n<p>    Contact: Vicki Cohn    <a href=\"mailto:vcohn@liebertpub.com\">vcohn@liebertpub.com<\/a>    914-740-2100 x2156    Mary    Ann Liebert, Inc.\/Genetic Engineering News<\/p>\n<p>    New Rochelle, NY, June 18, 2012A single-dose vaccine capable    of providing immunity against the effects of cocaine offers a    novel and groundbreaking strategy for treating cocaine    addiction is described in an article published Instant Online    in Human Gene Therapy, a peer-reviewed journal from Mary    Ann Liebert, Inc. (<a href=\"http:\/\/www.liebertpub.com\" rel=\"nofollow\">http:\/\/www.liebertpub.com<\/a>) The    article is available free online at the Human Gene    Therapy website (<a href=\"http:\/\/www.liebertpub.com\/hum\" rel=\"nofollow\">http:\/\/www.liebertpub.com\/hum<\/a>).  <\/p>\n<p>    \"This is a very novel approach for addressing the huge medical    problem of cocaine addiction,\" says James M. Wilson, MD, PhD,    Editor-in-Chief, and Director of the Gene Therapy Program,    Department of Pathology and Laboratory Medicine, University of    Pennsylvania Perelman School of Medicine, Philadelphia.  <\/p>\n<p>    In the article \"AAVrh.10-Mediated Expression of an Anti-Cocaine    Antibody Mediates Persistent Passive Immunization That    Suppresses Cocaine-Induced Behavior,\" (<a href=\"http:\/\/online.liebertpub.com\/doi\/pdfplus\/10.1089\/hum.2011.178\" rel=\"nofollow\">http:\/\/online.liebertpub.com\/doi\/pdfplus\/10.1089\/hum.2011.178<\/a>)    a team of researchers from Weill Cornell Medical College (New    York, NY), The Scripps Research Institute (La Jolla, CA), and    Cornell University (Ithaca, NY) used a virus-based delivery    vehicle in mice to transfer a gene that produces a protein    capable of binding to cocaine present in the blood, preventing    the cocaine from crossing into the brain. The protein is a    monoclonal antibody that sequesters cocaine, making the    vaccinated mice resistant to the drug's effects. Whereas    unvaccinated mice exhibited hyperactivity when exposed to    intravenous cocaine, the immunized mice showed no effects,    according to authors Jonathan Rosenberg, et al.  <\/p>\n<p>    ###  <\/p>\n<p>    About the Journal  <\/p>\n<p>    Human Gene Therapy (<a href=\"http:\/\/www.liebertpub.com\/hum\" rel=\"nofollow\">http:\/\/www.liebertpub.com\/hum<\/a>),    the Official Journal of the European Society of Gene and Cell    Therapy, British Society for Gene Therapy, French Society of    Cell and Gene Therapy, German Society of Gene Therapy, and five    other gene therapy societies is an authoritative peer-reviewed    journal published monthly in print and online that presents    reports on the transfer and expression of genes in mammals,    including humans. Related topics include improvements in vector    development, delivery systems, and animal models, particularly    in the areas of cancer, heart disease, viral disease, genetic    disease, and neurological disease, as well as ethical, legal,    and regulatory issues related to the gene transfer in humans.    Tables of contents and a free sample issue may be viewed online    at the Human Gene Therapy website (<a href=\"http:\/\/www.liebertpub.com\/hum\" rel=\"nofollow\">http:\/\/www.liebertpub.com\/hum<\/a>).  <\/p>\n<p>    About the Publisher  <\/p>\n<p>    Mary Ann Liebert, Inc. (<a href=\"http:\/\/www.liebertpub.com\" rel=\"nofollow\">http:\/\/www.liebertpub.com<\/a>) is a    privately held, fully integrated media company known for    establishing authoritative peer-reviewed journals in many    promising areas of science and biomedical research, including    Tissue Engineering, Stem Cells and Development, and    Cellular Reprogramming. Its biotechnology trade    magazine, Genetic Engineering & Biotechnology News    (GEN), was the first in its field and is today the    industry's most widely read publication worldwide. A complete    list of the firm's 70 journals, books, and newsmagazines is    available at the Mary Ann Liebert, Inc. website (<a href=\"http:\/\/www.liebertpub.com\" rel=\"nofollow\">http:\/\/www.liebertpub.com<\/a>).  <\/p>\n<\/p>\n<p>More:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2012-06\/mali-avd061812.php\" title=\"Anti-cocaine vaccine described in Human Gene Therapy Journal\">Anti-cocaine vaccine described in Human Gene Therapy Journal<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Public release date: 18-Jun-2012 [ | E-mail | Share ] Contact: Vicki Cohn <a href=\"mailto:vcohn@liebertpub.com\">vcohn@liebertpub.com<\/a> 914-740-2100 x2156 Mary Ann Liebert, Inc.\/Genetic Engineering News New Rochelle, NY, June 18, 2012A single-dose vaccine capable of providing immunity against the effects of cocaine offers a novel and groundbreaking strategy for treating cocaine addiction is described in an article published Instant Online in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc. (<a href=\"http:\/\/www.liebertpub.com\" rel=\"nofollow\">http:\/\/www.liebertpub.com<\/a>) The article is available free online at the Human Gene Therapy website (<a href=\"http:\/\/www.liebertpub.com\/hum\" rel=\"nofollow\">http:\/\/www.liebertpub.com\/hum<\/a>) <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/gene-therapy\/anti-cocaine-vaccine-described-in-human-gene-therapy-journal.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[24],"tags":[],"class_list":["post-47640","post","type-post","status-publish","format-standard","hentry","category-gene-therapy"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/47640"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=47640"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/47640\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=47640"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=47640"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=47640"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}